Johannesburg - Delayed Quote ZAc

Dis-Chem Pharmacies Limited (DCP.JO)

3,200.00
-20.00
(-0.62%)
As of 12:45:10 PM GMT+2. Market Open.
Loading Chart for DCP.JO
  • Previous Close 3,220.00
  • Open 3,178.00
  • Bid 3,195.00 x --
  • Ask 3,200.00 x --
  • Day's Range 3,178.00 - 3,205.00
  • 52 Week Range 2,650.00 - 4,000.00
  • Volume 60,045
  • Avg. Volume 1,263,353
  • Market Cap (intraday) 27.452B
  • Beta (5Y Monthly) 0.55
  • PE Ratio (TTM) 25.81
  • EPS (TTM) 1.24
  • Earnings Date May 30, 2025
  • Forward Dividend & Yield 0.54 (1.68%)
  • Ex-Dividend Date Nov 20, 2024
  • 1y Target Est 4,210.00

Dis-Chem Pharmacies Limited, together with its subsidiaries, engages in the retail and wholesale of healthcare products and pharmaceuticals in South Africa. The company operates through two segments, Retail and Wholesale. It owns and operates a chain of retail stores that offers a range of products, including dispensary, personal care and beauty, healthcare and nutrition, baby care, and other products. The company also offers a range of pharmaceutical, health, and front shop products in the wholesale market. In addition, it provides customer loyalty programs. The company was founded in 1978 and is headquartered in Midrand, South Africa.

dischemgroup.com

--

Full Time Employees

February 29

Fiscal Year Ends

Recent News: DCP.JO

View More

Performance Overview: DCP.JO

Trailing total returns as of 5/22/2025, which may include dividends or other distributions. Benchmark is All Share Index (^J203.JO) .

YTD Return

DCP.JO
11.36%
All Share Index (^J203.JO)
10.30%

1-Year Return

DCP.JO
5.03%
All Share Index (^J203.JO)
16.69%

3-Year Return

DCP.JO
4.41%
All Share Index (^J203.JO)
37.27%

5-Year Return

DCP.JO
75.45%
All Share Index (^J203.JO)
84.97%

Compare To: DCP.JO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: DCP.JO

View More

Valuation Measures

Annual
As of 5/21/2025
  • Market Cap

    27.61B

  • Enterprise Value

    32.16B

  • Trailing P/E

    26.03

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.73

  • Price/Book (mrq)

    5.69

  • Enterprise Value/Revenue

    0.85

  • Enterprise Value/EBITDA

    16.01

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.79%

  • Return on Assets (ttm)

    6.95%

  • Return on Equity (ttm)

    24.28%

  • Revenue (ttm)

    37.99B

  • Net Income Avi to Common (ttm)

    1.06B

  • Diluted EPS (ttm)

    1.24

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    824.41M

  • Total Debt/Equity (mrq)

    110.67%

  • Levered Free Cash Flow (ttm)

    665.19M

Research Analysis: DCP.JO

View More

Company Insights: DCP.JO

Research Reports: DCP.JO

View More

People Also Watch